EASL-ERN position paper on liver involvement in patients with Fontan-type circulation [0.03%]
EASL-ERN关于Fontan循环患者的肝病情况的立场文件
Luis Téllez,Audrey Payancé,Eric Tjwa et al.
Luis Téllez et al.
Fontan-type surgery is the final step in the sequential palliative surgical treatment of infants born with a univentricular heart. The resulting long-term haemodynamic changes promote liver damage, leading to Fontan-associated liver disease...
Practice Guideline
Journal of hepatology. 2023 Nov;79(5):1270-1301. DOI:10.1016/j.jhep.2023.07.013 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients [0.03%]
肝病和肝脏移植受者的新冠疫苗接种后的免疫反应和临床结果
Sam M Murray,Elisa Pose,Melanie Wittner et al.
Sam M Murray et al.
Background & aims: Comparative assessments of immunogenicity following different COVID-19 vaccines in patients with distinct liver diseases are lacking. SARS-CoV-2-specific T-cell and antibody responses were evaluated lon...
Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B [0.03%]
TP53BP2高表达与聚乙二醇干扰素治疗慢性乙肝患者HBsAg血清学转换相关性研究
Guiwen Guan,Ting Zhang,Jing Ning et al.
Guiwen Guan et al.
Background & aims: HBsAg loss is only observed in a small proportion of patients with chronic hepatitis B (CHB) who undergo interferon treatment. Investigating the host factors crucial for functional cure of CHB can aid i...
Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding [0.03%]
预测使用β受体阻滞剂+套扎治疗非高危急性静脉曲张出血患者的生存率
Lorenz Balcar,Mattias Mandorfer,Virginia Hernández-Gea et al.
Lorenz Balcar et al.
Background & aims: Pre-emptive transjugular intrahepatic portosystemic shunt (TIPS) is the treatment of choice for high-risk acute variceal bleeding (AVB; i.e., Child-Turcotte-Pugh [CTP] B8-9+active bleeding/C10-13). Neve...
Reply to: "Target mean arterial pressure in critically ill cirrhotic patients with septic shock: More is not always better!": High vs. low target mean arterial pressure in septic shock in cirrhosis - A personalized TARGET-C approach may solve the conundrum! [0.03%]
肝硬化患者脓毒性休克目标平均动脉压高的方案优于低的方案——TARGET-C个性化方法可解决这一难题！对《肝硬化合并脓毒性休克患者的靶向平均动脉压：越高越好吗？》一文的回答
Rakhi Maiwall,Samba Siva Rao Pasupuleti,Shiv Kumar Sarin
Rakhi Maiwall
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma [0.03%]
内皮细胞DGKG促进肝癌肿瘤血管生成和免疫逃逸
Liren Zhang,Jiali Xu,Suiqing Zhou et al.
Liren Zhang et al.
Background & aims: Hepatocellular carcinoma (HCC) is among the most prevalent and lethal cancers worldwide. The tumor microenvironment (TME) contributes to the poor response of patients with HCC to current therapies, whil...
Outcome of in situ split liver transplantation in Italy over the last 25 years: An alternative analysis and personal view [0.03%]
意大利原位劈离肝移植最后25年结局的另类分析及个人观点
Jean de Ville de Goyet
Jean de Ville de Goyet
Anticoagulation for cirrhosis with portal vein thrombosis: Still a road to be explored [0.03%]
肝硬化门静脉血栓的抗凝治疗：仍待探索的道路
Xiaoning Chen,Jinshui Pan,Yueyong Zhu
Xiaoning Chen
Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea [0.03%]
脂肪肝指数的纵向变化与韩国人群肝细胞癌风险的关系：一项基于全国范围队列研究的结果
Min Gu Kang,Chang Hun Lee,Chen Shen et al.
Min Gu Kang et al.
Comparing hypothermic oxygenated and normothermic liver machine perfusion: Translation matters [0.03%]
比较低温氧合与常温肝脏机器灌注：翻译很重要
Isabella Lurje,Deniz Uluk,Linda Hammerich et al.
Isabella Lurje et al.